David S Maxwell (David Maxwell)

Years Active: 2018-2020
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi, Victoria C Yan, Yasaman Barekatain, Sunada Khadka, Jeffrey J Ackroyd, Dimitra K Georgiou, Cong-Dat Pham, Kenisha Arthur, David S Maxwell, Zhenghong Peng, Paul G Leonard, Barbara Czako, Federica Pisaneschi, Pijus Mandal, Yuting Sun, Rafal Zielinski, Susana Castro Pando, Xiaobo Wang, Theresa Tran, Quanyu Xu, Qi Wu, Yongying Jiang, Zhijun Kang, John M Asara, Waldemar Priebe, William Bornmann, Joseph R Marszalek, Ronald A DePinho, Florian L Muller
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. Nature metabolism 2 (12) (2020)
Darren G Woodside, Eric A Tanifum, Ketan B Ghaghada, Ronald J Biediger, Amy R Caivano, Zbigniew A Starosolski, Sayadeth Khounlo, Saakshi Bhayana, Shahrzad Abbasi, John W Craft, David S Maxwell, Chandreshkumar Patel, Igor V Stupin, Deenadayalan Bakthavatsalam, Robert V Market, James T Willerson, Richard A F Dixon, Peter Vanderslice, Ananth V Annapragada
Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1. Scientific reports 8 (1) (2018)

David S Maxwell.css-eqlu8i{font-size:small;padding-left:4px;} (David Maxwell)